Coronavirus Update: No Mortality Gains From Remdesivir In WHO Trial, Gilead Questions Results

Trial Involved 11,000 Patients

WHO
The SOLIDARITY trial results have been praised by academic researcher leaders, but questioned by Gilead.

More from Business

More from Scrip